http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101149304-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23D9-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate | 2004-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101149304-B1 |
| titleOfInvention | Gastrointestinal Delivery System |
| abstract | The present invention relates to a capsule material for use with unstable therapeutic and nutrients on storage which release the therapeutic and nutrients at predetermined locations in the gastrointestinal tract, and is formed by combining food grade processed carbohydrates and food grade water soluble proteins. will be. The therapeutic and nutritional agents form an emulsified oil phase with a water dispersible or water soluble capsule to encapsulate the therapeutic and nutritional agents. These agents are oils or are oil soluble or oil dispersible. Formulations that can be encapsulated include lipids (oils including oxygen sensitive oils, fatty acids, triglycerides) and oil soluble and oil dispersible ingredients (including pharmaceuticals, probiotics, protein therapeutics and bioactive agents). Proteins used include any membrane forming water soluble protein or hydrolyzed protein, and milk proteins such as casein and derivatives or whey protein thereof. The carbohydrate component may be a component containing a reducing sugar group, oligosaccharide and starch (crude, modified, indigestible, acetylated, proprionylation and butylated starch). |
| priorityDate | 2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.